TWO SIGMA INVESTMENTS, LP - INNATE PHARMA S A ownership

INNATE PHARMA S A's ticker is IPHA and the CUSIP is 45781K204. A total of 13 filers reported holding INNATE PHARMA S A in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of INNATE PHARMA S A
ValueSharesWeighting
Q3 2022$38,000
-44.1%
18,789
-25.7%
0.00%
Q2 2022$68,000
-43.8%
25,289
-29.9%
0.00%
Q1 2022$121,000
-60.5%
36,089
-46.2%
0.00%
-100.0%
Q4 2021$306,000
+163.8%
67,055
+256.1%
0.00%
Q3 2021$116,00018,8290.00%
Other shareholders
INNATE PHARMA S A shareholders Q3 2022
NameSharesValueWeighting ↓
Rubric Capital Management LP 931,673$6,382,0000.73%
ADAGE CAPITAL PARTNERS GP, L.L.C. 500,000$3,425,0000.01%
WELLINGTON MANAGEMENT GROUP LLP 1,351,538$9,866,0000.00%
MILLENNIUM MANAGEMENT LLC 72,657$530,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 12,441$85,0000.00%
Steward Partners Investment Advisory, LLC 1,100$8,0000.00%
OSAIC HOLDINGS, INC. 2,000$14,0000.00%
View complete list of INNATE PHARMA S A shareholders